DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹4,643 Cr | ₹4,543 Cr | ₹5,888 Cr | ₹2,811 Cr | ₹3,570 Cr |
What is the latest Cash Flow from Operating Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹4,643 Cr |
| Mar2024 | ₹4,543 Cr |
| Mar2023 | ₹5,888 Cr |
| Mar2022 | ₹2,811 Cr |
| Mar2021 | ₹3,570 Cr |
How is Cash Flow from Operating Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,643 Cr | 2.19 | |
| Mar2024 | ₹4,543 Cr | -22.83 | |
| Mar2023 | ₹5,888 Cr | 109.46 | |
| Mar2022 | ₹2,811 Cr | -21.27 | |
| Mar2021 | ₹3,570 Cr | - | |
Compare Cash Flow from Operating Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹107,429.7 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| MANKIND PHARMA | ₹92,784.1 Cr | 9.9% | 5.8% | -2% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -1.5% |
5.7% |
14.5% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses